These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4623214)

  • 41. [Reoperation for severe hematuria following chemotherapy for bladder papillomatosis previously treated by surgery and cobalt therapy].
    Sauvage R
    Acta Urol Belg; 1981 Jan; 49(1):36-43. PubMed ID: 6782845
    [No Abstract]   [Full Text] [Related]  

  • 42. [Prognostic factors and risk of recurrence in a series of 385 patients with superficial bladder carcinoma treated with thiotepa, adriamycin or cisplatin].
    Llopis B; Sánchez A; Boronat F; Gallego J; Moreno B; Alonso M; Martínez R; Vera CD; Jiménez JF
    Arch Esp Urol; 1987 Apr; 40(3):159-64. PubMed ID: 3113347
    [No Abstract]   [Full Text] [Related]  

  • 43. [Verification of the effectiveness of Thio-Tepa on tumor tissue in local chemotherapy of bladder papillomatosis].
    Lunglmayr G; Kellner G; Czech K
    Urol Int; 1970; 25(5):493-501. PubMed ID: 5004171
    [No Abstract]   [Full Text] [Related]  

  • 44. [Intravascular thio-tepa in the treatment of papillary neoplasms of the bladder].
    Furnari S; Lattuca C; Pavone-Macaluso M; Leone G
    Arch Ital Urol Nefrol; 1968; 41(3):187-98. PubMed ID: 4982415
    [No Abstract]   [Full Text] [Related]  

  • 45. [Round-table: Chemotherapy of bladder tumors].
    J Urol Nephrol (Paris); 1979 Sep; 85 Suppl 2():179-206. PubMed ID: 116009
    [No Abstract]   [Full Text] [Related]  

  • 46. [Personal experience with treatment of vesical tumors by instillation of a cytostatic (preliminary report)].
    Wainberg S; Budich M; Paredes R; Leisner M
    Rev Argent Urol Nefrol; 1969; 38(10):430-2. PubMed ID: 4989830
    [No Abstract]   [Full Text] [Related]  

  • 47. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
    Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparative study of thiotepa, adriamycin and cisplatin in the prophylaxis of recurrence of superficial bladder carcinoma in a group of 217 patients].
    Llopis B; Gallego J; Boronat F; Moreno B; Mompó JA; Jiménez JF
    Actas Urol Esp; 1986; 10(4):225-30. PubMed ID: 3092589
    [No Abstract]   [Full Text] [Related]  

  • 49. [Conservative treatment of vesical papillomatosis using vitamin A acid. Preliminary report].
    Evard JP
    Helv Chir Acta; 1971 Dec; 38(5):541-3. PubMed ID: 5152168
    [No Abstract]   [Full Text] [Related]  

  • 50. Single dose intravesical thiotepa as an adjuvant to cystodiathermy in the treatment of transitional cell bladder carcinoma.
    Burnand KG; Boyd PJ; Mayo ME; Shuttleworth KE; Lloyd-Davies RW
    Br J Urol; 1976 Feb; 48(1):55-9. PubMed ID: 817761
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparative study of thiotepa and adriamycin as preventive intravesical treatment in non-infiltrating bladder tumors].
    Lancina Martín JA; Mateo Cambón L; Casas Muiño RA; González Martín M
    Actas Urol Esp; 1983; 7(4):269-74. PubMed ID: 6414263
    [No Abstract]   [Full Text] [Related]  

  • 52. The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder.
    Koontz WW; Prout GR; Smith W; Frable WJ; Minnis JE
    J Urol; 1981 Mar; 125(3):307-12. PubMed ID: 6782251
    [No Abstract]   [Full Text] [Related]  

  • 53. Optimal intravesical dosage of thio-tepa in the prophylaxis of recurrent bladder papillomatosis.
    Oravisto KJ
    Scand J Urol Nephrol; 1972; 6(1):26-8. PubMed ID: 4626940
    [No Abstract]   [Full Text] [Related]  

  • 54. [Thio-tepa in the prevention of recurrences of papillary bladder tumors].
    Kierfeld G; Mellin P
    Z Urol Nephrol; 1973 Aug; 66(8):569-72. PubMed ID: 4204011
    [No Abstract]   [Full Text] [Related]  

  • 55. Prophylactic effect of triethylenethiophosphoramide on the recurrence rate of superficial bladder tumors.
    Mukamel E; Zitron S; Nissenkorn I; Servadio C
    Isr J Med Sci; 1980; 16(9-10):714-6. PubMed ID: 6776072
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prevention of the recurrence of bladder tumors with local adriamycin therapy].
    Somogyi L; Török A; Bors G; Frang D
    Orv Hetil; 1984 Oct; 125(41):2503-6. PubMed ID: 6493764
    [No Abstract]   [Full Text] [Related]  

  • 57. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M; McGarry R; Kupelnick B
    Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Progress in the internist treatment of bladder tumors].
    Baumgartner G
    Wien Med Wochenschr; 1982 Jul; 132(13-14):305-12. PubMed ID: 6814073
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemotherapy for bladder cancer.
    Veenema RJ; Romas NA; Fingerhut B
    Urology; 1974 Feb; 3(2):135-9. PubMed ID: 4204755
    [No Abstract]   [Full Text] [Related]  

  • 60. [Local chemotherapy of papillary neoplasms of the bladder].
    Pavone-Macaluso M
    Pol Tyg Lek; 1973 Apr; 28(14):523-30. PubMed ID: 4633501
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.